Blocking creatine metabolism slows the growth of cancer tumors in laboratory animals with leukemia, prostate cancer, and colon cancer.
From A New Study Just Linked Creatine To Cancer · videoSee the scientific wording
Pharmacological inhibition of creatine metabolism reduces tumor growth in preclinical models of leukemia, prostate cancer, and colon cancer.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor
Cohort StudyIn vitro2023
This study shows that a drug blocking creatine use kills leukemia cells in a lab dish, which supports part of the claim, but it didn't test prostate or colon cancer, so the claim is too broad.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
A drug locks onto an enzyme that cells need to manage their energy. Without this enzyme, energy storage molecules drop and the cell cannot maintain its energy balance. The cell senses this stress and activates a DNA damage alert system. This alert system halts cell division and eventually causes the cell to self-destruct.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Blocking creatine metabolism slows the growth of cancer tumors in laboratory animals with leukemia, prostate cancer, and colon cancer.
Mechanism
1 studyA targeted drug blocks a key energy enzyme in leukemia cells, causing an energy crisis. The cells respond by activating a stress pathway that stops them from dividing and forces them to die. This explains how the drug kills leukemia cells, but evidence is lacking for other cancers mentioned in the claim.
A drug locks onto an enzyme that cells need to manage their energy. Without this enzyme, energy storage molecules drop and the cell cannot maintain its energy balance. The cell senses this stress and activates a DNA damage alert system. This alert system halts cell division and eventually causes the cell to self-destruct.
CKi covalently binds to the active site cysteine of creatine kinase isoforms (CKB, CKMT1), blocking the enzyme's phosphotransfer activity.
Creatine kinase inhibition prevents bidirectional phosphotransfer between ATP and creatine, depleting phosphocreatine levels and reducing the ATP/ADP ratio.
Energetic stress from the decreased ATP/ADP ratio activates DNA damage response kinases ATM, ATR, and DNAPK.
Activation of these kinases triggers cell cycle arrest at G0/G1 and G2/M phases.
Cell cycle arrest leads to apoptosis (programmed cell death) in creatine kinase-dependent leukemia cells.
Evidence from Studies
Last searched 2mo ago
Supporting (1)
Community contributions welcome
Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor
This study shows that a drug blocking creatine use kills leukemia cells in a lab dish, which supports part of the claim, but it didn't test prostate or colon cancer, so the claim is too broad.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
Clinical support requires direct evidence. Mechanistic proxy and tangential studies contribute only to the mechanistic score.
- All linked studies are tangential or mechanistic proxies — no direct test of the claim has been found.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Pharmacological Inhibition of Creatine Metabolism on Tumor Growth in Preclinical Cancer Models
Comprehensive search of animal studies on pharmacological inhibition of creatine metabolism in leukemia, prostate cancer, and colon cancer models, with meta-analysis of tumor growth outcomes.
Controlled Animal Experiment of Creatine Metabolism Inhibitor in Leukemia, Prostate Cancer, and Colon Cancer Xenografts
Randomized, placebo-controlled experiment in mice bearing xenografts of leukemia, prostate cancer, and colon cancer, with treatment group receiving a specific creatine metabolism inhibitor, measuring tumor volume and weight over a defined period.
Expert Consensus on the Role of Creatine Metabolism in Cancer
Survey or consensus statement from leading oncologists and biochemists on the plausibility and implications of targeting creatine metabolism in cancer therapy.